Abstract
Objective
To compare the cancer-specific survival (CSS) among patients with locally advanced laryngeal squamous cell carcinoma (LSCC) receiving chemoradiotherapy (CRT) and radiotherapy (RT) treatment, as well as to establish a prognostic nomogram for survival prediction in patients receiving CRT.
Method
Using data from the Surveillance, Epidemiology, and End Results (SEER) database, patients with laryngeal cancer were identified between 2010 and 2015, with follow-up up to 2018. Propensity score matching (PSM) was performed to minimize disproportionate distributions of the potential confounding. Cox regression models were used to evaluate the CSS of two treatment groups. A prognostic nomogram for patients receiving CRT was then developed and evaluated.
Results
Totally 1085 non-surgical patients with locally advanced LSCC were included in this study (median [IQR] age, 62 [55–69] years; 829 [76.41%] males), of which 913 receiving CRT and 172 receiving RT. After PSM, significantly improved CSS was observed in locally advanced LSCC patients receiving CRT when compared to RT (HR: 0.62 [95% CI 0.42–0.92]; P = 0.014). Then, in the group of 639 locally advanced LSCC patients receiving CRT, a prognostic nomogram based on age, tumor size, N category, and marital status were developed and validated, of which the predictive performance was superior to that of TNM staging system (7th edition).
Conclusion
CSS shows a statistically significant improvement in locally advanced LSCC patients who receipt of CRT when compared with RT. Furthermore, a prognostic nomogram for locally advanced LSCC patients receiving CRT was established, which shows a good calibration and identification accuracy.
Similar content being viewed by others
Data availability
All methods were carried out in accordance with relevant guidelines and regulations. The data that support the findings of this study are openly available in SEER database at https://seer.cancer.gov/.
References
Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A (2015) Global cancer statistics. Cancer J Clin 65(2):87–108
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394–424
Steuer CE, El-Deiry M, Parks JR, Higgins KA, Saba NF (2017) An update on larynx cancer. Cancer J Clin 67(1):31–50
Randa O, Magi R, Chafeek T (2019) The treatment of laryngeal cancer. Oral Maxillofac Surg Clin N Am 31(1):1–11
Pfister DG, Laurie SA, Weinstein GS (2006) American Society of Clinical Oncology clinical practice guideline for the use of larynx-preservation strategies in the treatment of laryngeal cancer. J Clin Oncol 24:3693–3704
Wolf GT, Fisher SG, Hong WK, Hillman R, Spaulding M, Laramore GE (1991) Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med 324:1685–1690
Karlsson TR, Al-Azzawe M, Aziz L et al (2014) Survival outcome depending on different treatment strategies in advanced stages III and IV laryngeal cancers: an audit of data from two European centres. Eur Arch Otorhinolaryngol 271:547–554
National Comprehensive Cancer Network (NCCN) (2017). Clinical practice guidelines in oncology. Head and Neck Cancer. https://www.nccn.org/professionals/physician_gls/. Accessed 30 Oct 2019.
Cohen EE, Karrison TG, Kocherginsky M, Mueller J, Egan R, Huang CH, Samant S (2014) Phase III randomized trial of induction chemotherapy in patients with N2 or N3 locally advanced head and neck cancer. J Clin Oncol 32(25):2735–2743
Haddad R, O’Neill A, Rabinowits G, Tishler R, Khuri F, Adkins D, Limaye S (2013) Induction chemotherapy followed by concurrent chemoradiotherapy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced head and neck cancer (PARADIGM): a randomised phase 3 trial. Lancet Oncol 14(3):257–264
Kitani Y, Kubota A, Furukawa M, Sato K (2016) Prognostic factors for local control in patients receiving radiation therapy for early glottic cancer: anterior commissure involvement and effect of chemoradiotherapy. Eur Arch Otorhinolaryngol 273:1011–1017
Lagha A, Chraiet N, Labidi S, Rifi H, Ayadi M, Krimi S, Kochbati L (2013) Larynx preservation: what is the best non-surgical strategy? Crit Rev Oncol Hematol 88(2):447–458
Forastiere AA, Zhang Q, Weber RS, Maor MH, Goepfert H, Pajak TF, Thorstad W (2013) Long-term results of RTOG 91–11: a comparison of three nonsurgical treatment strategies to preserve the larynx in patients with locally advanced larynx cancer. J Clin Oncol 31(7):845–852
Karlsson TR, Al-Azzawe M, Aziz L, Hurman D, Finizia C (2014) Survival outcome depending on different treatment strategies in advanced stages III and IV laryngeal cancers: an audit of data from two European centres. Eur Arch Otorhinolaryngol 271(3):547–554
Department of Veterans Affairs Laryngeal Cancer Study Group (1991) Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med 324(24):1685–1690
Wolf GT, Bellile E, Eisbruch A (2017) Survival rates using individualized bioselection treatment methods in patients with advanced laryngeal cancer. JAMA Otolaryngol Head Neck Surg 143:355–366
Bonner J, Giralt J, Harari P (2016) Cetuximab and radiotherapy in laryngeal preservation for cancers of the larynx and Hypopharynx: a secondary analysis of a randomized clinical trial. JAMA Otolaryngol Head Neck Surg 142:842–849
Leoncini E, Vukovic V, Cadoni G (2018) Tumour stage and gender predict recurrence and second primary malignancies in head and neck cancer: a multicentre study within the INHANCE consortium. Eur J Epidemiol 33:1205–1218
Li ZQ, Zou L, Liu TR, Yang AK (2015) Prognostic value of body mass index before treatment for laryngeal squamous cell carcinoma. Cancer Biol Med 12:394–400
Daneshi N, Fararouei M, Mohammadianpanah M et al (2018) Effects of different treatment strategies and tumor stage on survival of patients with advanced laryngeal carcinoma: a 15-year cohort study. J Cancer Epidemiol 2018:9678097
Balachandran VP, Gonen M, Smith JJ, DeMatteo RP (2015) Nomograms in oncology: more than meets the eye. Lancet Oncol 16(4):e173–e180
Zhu X, Heng Y, Zhou L et al (2019) A prognostic nomogram for predicting risk of recurrence in laryngeal squamous cell carcinoma patients after tumor resection to assist decision making for postoperative adjuvant treatment. J Surg Oncol 120:698–706
Chen F, Lin L, Liu F, Yan L, Qiu Y, Wang J, Wang R (2019) Three prognostic indexes as predictors of response to adjuvant chemoradiotherapy in patients with oral squamous cell carcinoma after radical surgery: a large-scale prospective study. Head Neck 41(2):301–308
Santoro L, Tagliabue M, Massaro MA, Ansarin M, Calabrese L, Giugliano G, Benazzo M (2015) Algorithm to predict postoperative complications in oropharyngeal and oral cavity carcinoma. Head Neck 37(4):548–556
Hay A, Migliacci J, Zanoni DK, Patel S, Yu C, Kattan MW, Ganly I (2018) Validation of nomograms for overall survival, cancer-specific survival, and recurrence in carcinoma of the major salivary glands. Head Neck 40(5):1008–1015
Petersen JF, Stuiver MM, Timmermans AJ, Chen A, Zhang H, O’Neill JP, Skroder C (2018) Development and external validation of a risk-prediction model to predict 5-year overall survival in advanced larynx cancer. Laryngoscope 128(5):1140–1145
Sawant SS, Dongre H, Ahire C, Sharma S, Kannan S, Mahadik S, Vaidya MM (2017) A nomogram for predicting the risk of neck node metastasis in pathologically node-negative oral cavity carcinoma. Oral Dis 23(8):1087–1098
Wang SJ, Patel SG, Shah JP, Goldstein DP, Irish JC, Carvalho AL, Gross ND (2013) An oral cavity carcinoma nomogram to predict benefit of adjuvant radiotherapy. JAMA Otolaryngol Head Neck Surg 139(6):554–559
Sheu T, Fuller CD, Mendoza TR, Garden AS, Morrison WH, Beadle BM, Cleeland CS (2014) Nomogram for predicting symptom severity during radiation therapy for head and neck cancer. Otolaryngology Head Neck Surg 151(4):619–626
Funding
No funding has been received for this work.
Author information
Authors and Affiliations
Contributions
YZ and YZ performed the formal analysis; ZW and YZ performed the data analysis; Yuan Zhang wrote the manuscript.
Corresponding author
Ethics declarations
Conflict of interest
We declare no conflict of interest.
Ethical approval
Not applicable. This article does not contain any studies with human participants or animals performed by any of the authors.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Zhang, Y., Wang, Z. & Zheng, Y. Chemoradiotherapy vs radiotherapy for non-surgical locally advanced laryngeal squamous cell carcinoma patients: a propensity score-matched study and practical nomogram construction. Eur Arch Otorhinolaryngol 281, 1449–1456 (2024). https://doi.org/10.1007/s00405-023-08360-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00405-023-08360-8